申请人:Betta Pharmaceuticals Co., Ltd.
公开号:US20210395256A1
公开(公告)日:2021-12-23
The present invention relates to compounds of Formula I, methods of using the compounds as Trk inhibitors, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.